Latest Capital Raising News

Castile Resources has validated a cutting-edge seismic method to pinpoint ironstone orebodies, setting the stage for a major drilling campaign and a robust Bankable Feasibility Study backed by a $4.1 million capital raise.

Pioneer Lithium Limited has lifted its trading suspension following the announcement of a proposed material acquisition and capital raising, signaling a pivotal moment for the company’s growth strategy.

Aumake Limited reported a remarkable 239% increase in quarterly cash receipts, driven by a $16 million purchase order from Yangtze River and a strategic capital raise, positioning the company for robust growth in 2025.

Bellavista Resources has secured nearly A$5 million in capital to fund due diligence on advanced precious and base metal projects, while maintaining a strong cash position and progressing exploration at its Brumby Deposit.

AML3D Limited has reported a strong December quarter marked by significant defense contract completions, a $30 million capital raise, and strategic expansion into the US and European markets. The company is poised for accelerated growth, underpinned by a major US Navy funding boost and new sector entries.

Element 25 Limited has successfully raised AU$2.85 million through an at-the-market share placement with Acuity Capital, issuing 8.7 million shares at a premium price to bolster its working capital.

Prodigy Gold's December 2024 quarterly report reveals significant high-grade gold intercepts at its Hyperion and Tregony projects, alongside progress on metallurgical testing and a new Mineral Lease application. The company maintains a solid cash position with no debt, positioning itself for an active 2025 exploration season.

ioneer Ltd’s December 2024 quarterly cash flow report reveals ongoing cash outflows from operations and investing, with nearly $4.5 million spent this quarter but a solid cash reserve providing a runway of almost five quarters.

Tryptamine Therapeutics has reported successful Phase 1b results for its IV-infused psilocin candidate TRP-8803 and promising interim data for oral psilocybin TRP-8802 in IBS treatment, while securing $6 million in new funding to accelerate clinical development.

A1 Investments & Resources Ltd reported a modest cash outflow for Q1 2024 while actively pursuing renewable energy acquisitions in Japan and Australia, contingent on regulatory approvals and shareholder consent.

OpenLearning Limited reported a 23% year-on-year increase in SaaS annual recurring revenue to $2.335 million in Q4 FY24, driven by strong growth in AI-powered products and strategic partnerships. The company also cut net operating cash outflows by over half, signaling improved operational efficiency.

NEXION Group reported a robust 30% increase in cash receipts for Q2 FY25, driven by strong sales growth and new satellite sector contracts. The company is actively expanding its footprint in Southeast Asia while funding ongoing M&A activities through convertible notes.